1-4 of 4
Tomomi M. Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval

Kimberly R. Jordan, Matthew J. Sikora, Jill E. Slansky, Angela Minic, Jennifer K. Richer, Marisa R. Moroney, Junxiao Hu, Rebecca J. Wolsky, Zachary L. Watson, Tomomi M. Yamamoto, James C. Costello, Aaron Clauset, Kian Behbakht, T. Rajendra Kumar, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6362–6373.
https://doi.org/10.1158/1078-0432.CCR-20-1762
Published: 01 December 2020
View article titled, The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Open the PDF for The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval in another window
Includes: Supplementary data
Journal Articles

Abstract A77: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma

Zachary L. Watson, Tomomi M. Yamamoto, Connor J. Hughes, Lindsay J. Wheeler, Miriam D. Post, Kian Behbakht, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A77.
https://doi.org/10.1158/1557-3265.OVCA19-A77
Published: 01 July 2020
View article titled, Abstract A77: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
Journal Articles

Abstract GMM-040: TARGETING WNT SIGNALING TO OVERCOME PARP INHIBITOR RESISTANCE

Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Jennifer Aguilera, Matthew J. Sikora, Rebecca Ferguson, Elmar Numammadov, George-Lucian Moldovan, Tanay Thakar, Hyunmin Kim, Diana M. Cittelly, Heidi Wilson, Kian Behbakht, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): GMM-040.
https://doi.org/10.1158/1557-3265.OVCASYMP18-GMM-040
Published: 15 November 2019
View article titled, Abstract GMM-040: TARGETING WNT SIGNALING TO OVERCOME PARP INHIBITOR RESISTANCE
Journal Articles

Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen

Heather M. Brechbuhl, Jessica Finlay-Schultz, Tomomi M. Yamamoto, Austin E. Gillen, Diana M. Cittelly, Aik-Choon Tan, Sharon B. Sams, Manoj M. Pillai, Anthony D. Elias, William A. Robinson, Carol A. Sartorius, Peter Kabos
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (7): 1710–1721.
https://doi.org/10.1158/1078-0432.CCR-15-2851
Published: 02 April 2017
View article titled, Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
Open the PDF for Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen in another window
Includes: Supplementary data